2 ASX 50 shares to buy for your retirement portfolio

Here's why I believe Coles Group Ltd (ASX:COL) and this excellent ASX 50 share could be top options for retirees right now…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for additions to your retirement portfolio, then I think the ASX 50 index is a great place to start.

The ASX 50 index is a large cap index which has been designed to represent 50 of the largest and most liquid shares listed on the ASX based on their float-adjusted market capitalisation.

But which ASX 50 shares should you buy? I think the two listed below could be top options right now:

Coles Group Ltd (ASX: COL)

I think that Coles is one of the best shares for a retiree to own right now. This is due to its solid long term growth potential, cost cutting, generous dividend policy, and defensive qualities. The supermarket giant has displayed the latter this year with its strong sales and profit growth during the pandemic. Coles reported a 6.9% increase in sales to $37.4 billion and a 7.1% lift in net profit after tax to $951 million in FY 2020.

The good news is that the company has started the new financial year strongly and looks well placed to deliver another solid profit result in FY 2021. This should put Coles in a position to reward shareholders with another generous dividend next year. Based on the current Coles share price, I estimate that it offers a fully franked FY 2021 3.3% dividend yield.

CSL Limited (ASX: CSL)

I think this biotherapeutics giant CSL would be a good addition to a retirement portfolio. While it may not provide investors with an overly attractive yield, I believe its dividend can grow strongly over the next decade thanks to its positive long term outlook.

This is thanks to its talented management team, its lucrative research and development pipeline, and the strength of its existing therapies and vaccines. The latter include key immunoglobulins products such as Privgen and Hizentra and haemophilia products Idelvion and Afstyla. Combined, I believe they have positioned CSL to deliver consistently solid earnings growth over the 2020s and beyond.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »